CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Commercial Officer bought 279 shares at $3.55 ($990)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Shares withheld for taxes General Counsel and Secretary gave up 17,377 shares (to pay taxes)
- 4 Open-market buy General Counsel and Secretary bought 5,000 shares at an average $2.21 ($11,035)
- 4 Open-market buy Chief Medical Officer bought 3,000 shares at $2.24 ($6,720)
- 4 Open-market buy Director bought 100,000 shares at an average $2.26 ($225,854)
- 4 Open-market buy Chief Commercial Officer bought 3,715 shares at $1.98 ($7,356)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $2.11 ($21,100)
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 27 of 41 · 802 filings